Multi-disciplinary strategic pre-launch and launch expert, visionary and innovative Commercial/Brand leader who has had successful results with the strategic planning, implementation and team leadership for some of the largest and influential pharmaceutical brand launches in the last 10 years. Through Promo Med Ed, HCP Promotion, Market Access and PR channels, has directed full life-cycle development, from early commercial, medical need/disease shaping at phase 2 (Ilaris), brand development (KEYTRUDA), franchise positioning (BMS PD1) and Post LOE strategy (Lipitor).

Has helped develop breakthrough medical communication platforms in each category: KEYTUDA (Immuno-oncology/PD1 Inhibitor); PRADAXA (Stroke); Lipitor (Cardiovascular) ATRIPLA (HIV); BOTOX, VIMPAT (CNS), successfully developing education and communication strategies that shift KOL and specialists mindsets, leading to the transformation of medical paradigms and treatment norms.

Has track record of leading these high profile brands with large integrated multi-disciplinary teams; Has significantly increased business, brand budgets and won pitches; Has developed the strategic plans that have overcome brand challenges and optimized market opportunities to obtain successful short and long term brand results.

On the forefront of tracking advanced scientific thinking, has remodeled scientific led communication plans to define a medical need, working with top Key Opinion Leaders to develop and validate that scientific communication strategy.

Has projected, planned and helped create “what’s next” in healthcare